Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions
Ara mostrant els elements 1-5 d 865
-
Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series
(Dove Medical Press, 2024-03-29)